[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 215
71. Mignanelli ED, de Campos-Lobato LF, Stocchi L, Lavery IC, Dietz DW: Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? Dis Colon Rectum; 2010 Mar;53(3):251-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye?
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Dis Colon Rectum. 2010 Jun;53(6):960. Campos-Lobato, Luiz F [corrected to de Campos-Lobato, Luiz F]
  • (PMID = 20173469.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Grahn BH, Peiffer RL, Cullen CL, Haines DM: Classification of feline intraocular neoplasms based on morphology, histochemical staining, and immunohistochemical labeling. Vet Ophthalmol; 2006 Nov-Dec;9(6):395-403
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These included four neoplasms morphologically diagnosed as lymphosarcomas but which expressed differentiation antigens consistent with melanoma (n = 3) or ciliary adenocarcinoma (n = 1), and four tumors morphologically diagnosed as intraocular sarcomas that expressed differentiation antigens for melanoma (n = 2), metastatic carcinoma (n = 1), or remained undifferentiated (n = 1).
  • Immunohistochemical labeling suggested a diagnosis in 5/6 morphologically undifferentiated neoplasms including one intraocular sarcoma, two diffuse iridal melanomas, and two ciliary adenocarcinomas.
  • [MeSH-major] Algorithms. Cat Diseases / diagnosis. Eye Neoplasms / veterinary
  • [MeSH-minor] Adenoma / diagnosis. Adenoma / veterinary. Animals. Biomarkers, Tumor. Cats. Immunohistochemistry / veterinary. Lymphoma, Non-Hodgkin / diagnosis. Lymphoma, Non-Hodgkin / veterinary. Melanoma / diagnosis. Melanoma / veterinary. Sarcoma / diagnosis. Sarcoma / veterinary

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17076872.001).
  • [ISSN] 1463-5216
  • [Journal-full-title] Veterinary ophthalmology
  • [ISO-abbreviation] Vet Ophthalmol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


73. Ciccoli R, Sahi S, Singh S, Prakash H, Zafiriou MP, Ishdorj G, Kock JL, Nigam S: Oxygenation by COX-2 (cyclo-oxygenase-2) of 3-HETE (3-hydroxyeicosatetraenoic acid), a fungal mimetic of arachidonic acid, produces a cascade of novel bioactive 3-hydroxyeicosanoids. Biochem J; 2005 Sep 15;390(Pt 3):737-47
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / enzymology. Animals. Candida albicans / drug effects. Cell Line. Cyclooxygenase 1 / metabolism. Electrophysiology. HeLa Cells. Humans. Kinetics. Molecular Structure. Oxidation-Reduction. Sheep. Substrate Specificity. Trabecular Meshwork / metabolism

  • Hazardous Substances Data Bank. OXYGEN .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] FEMS Microbiol Lett. 2001 Apr 20;198(1):37-43 [11325551.001]
  • [Cites] J Immunol. 2002 Oct 15;169(8):4586-93 [12370397.001]
  • [Cites] J Biol Chem. 2002 Jan 25;277(4):2614-9 [11706038.001]
  • [Cites] J Immunol. 2003 Sep 15;171(6):3047-55 [12960330.001]
  • [Cites] Prostaglandins Other Lipid Mediat. 2003 Jul;71(3-4):85-96 [14518554.001]
  • [Cites] Proc Natl Acad Sci U S A. 1973 Mar;70(3):899-903 [4514999.001]
  • [Cites] J Biol Chem. 1990 Nov 25;265(33):20073-6 [2122967.001]
  • [Cites] Biochim Biophys Acta. 1991 Apr 24;1083(1):1-17 [1903304.001]
  • [Cites] FEBS Lett. 1991 Jun 3;283(2):195-8 [1904371.001]
  • [Cites] J Pediatr. 1992 Jul;121(1):1-11 [1625065.001]
  • [Cites] Nature. 1994 Jan 20;367(6460):243-9 [8121489.001]
  • [Cites] J Biol Chem. 1994 May 6;269(18):13207-15 [8175750.001]
  • [Cites] FEBS Lett. 1994 Jun 6;346(1):21-5 [8206152.001]
  • [Cites] Cell. 1995 Nov 3;83(3):483-92 [8521478.001]
  • [Cites] J Biol Chem. 1995 Dec 8;270(49):29372-7 [7493972.001]
  • [Cites] Bioessays. 1995 Dec;17(12):1031-7 [8634064.001]
  • [Cites] Biochim Biophys Acta. 1996 Jan 5;1299(1):125-40 [8555245.001]
  • [Cites] J Biol Chem. 1996 Jan 26;271(4):2179-84 [8567676.001]
  • [Cites] Biochemistry. 1996 Jun 11;35(23):7330-40 [8652509.001]
  • [Cites] Adv Immunol. 1996;62:167-215 [8781269.001]
  • [Cites] Nat Struct Biol. 1996 Nov;3(11):927-33 [8901870.001]
  • [Cites] Nature. 1996 Dec 19-26;384(6610):644-8 [8967954.001]
  • [Cites] J Biol Chem. 1997 Apr 4;272(14):9280-6 [9083063.001]
  • [Cites] Lipids. 1997 Dec;32(12):1277-83 [9438238.001]
  • [Cites] Arch Biochem Biophys. 1998 Jan 15;349(2):376-80 [9448728.001]
  • [Cites] J Biol Chem. 1998 Apr 10;273(15):8903-9 [9535872.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 1998;38:97-120 [9597150.001]
  • [Cites] Biochim Biophys Acta. 1999 Nov 23;1441(2-3):278-87 [10570255.001]
  • [Cites] J Biol Chem. 2000 Mar 3;275(9):6586-91 [10692466.001]
  • [Cites] Exp Eye Res. 2000 Mar;70(3):285-93 [10712815.001]
  • [Cites] Biochim Biophys Acta. 2000 Jul 19;1486(2-3):299-311 [10903481.001]
  • [Cites] Antonie Van Leeuwenhoek. 2000 May;77(4):401-6 [10959570.001]
  • [Cites] J Biol Chem. 2000 Oct 27;275(43):33744-9 [10931854.001]
  • [Cites] Lipids. 2000 Nov;35(11):1205-14 [11132180.001]
  • [Cites] FEBS Lett. 1998 May 15;427(3):345-8 [9637254.001]
  • [Cites] FASEB J. 1998 Sep;12(12):1063-73 [9737710.001]
  • [Cites] Biochem Biophys Res Commun. 1998 Dec 30;253(3):703-6 [9918790.001]
  • [Cites] J Biol Chem. 1999 Jun 11;274(24):17109-14 [10358065.001]
  • [Cites] J Biol Chem. 1999 Aug 13;274(33):22903-6 [10438452.001]
  • [Cites] J Biol Chem. 1999 Aug 13;274(33):23305-10 [10438506.001]
  • [Cites] Physiol Rev. 1999 Oct;79(4):1193-226 [10508233.001]
  • [Cites] Can J Biochem Physiol. 1959 Aug;37(8):911-7 [13671378.001]
  • [Cites] J Immunol. 2004 Nov 15;173(10):5952-62 [15528329.001]
  • [Cites] FEBS Lett. 2002 May 8;518(1-3):154-8 [11997037.001]
  • [Cites] J Biol Chem. 2002 Jan 4;277(1):478-85 [11677234.001]
  • (PMID = 15869467.001).
  • [ISSN] 1470-8728
  • [Journal-full-title] The Biochemical journal
  • [ISO-abbreviation] Biochem. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Hydroxyeicosatetraenoic Acids; 135295-02-2 / 3-hydroxy-5,8,11,14-eicosatetraenoic acid; EC 1.14.99.1 / Cyclooxygenase 1; EC 1.14.99.1 / Cyclooxygenase 2; S88TT14065 / Oxygen
  • [Other-IDs] NLM/ PMC1326017
  •  go-up   go-down


7
Advertisement
4. Lee SW, Park SH, Kim IH, Chung H, Kim TY, Heo DS: Nonsurgical treatment of an incompletely excised primary adenocarcinoma of nonpigmented ciliary epithelium. Tumori; 2007 Sep-Oct;93(5):514-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonsurgical treatment of an incompletely excised primary adenocarcinoma of nonpigmented ciliary epithelium.
  • Primary adenocarcinoma of the nonpigmented ciliary epithelium (NPCE) is a very rare disease and the majority of acquired cases were treated by enucleation.
  • We report the case of a 19-year-old man who had an adenocarcinoma arising from the NPCE.
  • An excisional biopsy was performed and histopathological examination showed primary adenocarcinoma of the NPCE with a positive resection margin.
  • Because of the positive resection margin and to save the eye, radiotherapy rather than enucleation was performed, followed by chemotherapy.
  • Two years after the diagnosis, the patient continues to be followed up without evidence of relapse or cataract change.
  • [MeSH-major] Adenocarcinoma / therapy. Ciliary Body. Uveal Neoplasms / therapy
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Pigment Epithelium of Eye / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18038890.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


75. Kurunmäki H, Kantola R, Hatamleh MM, Watts DC, Vallittu PK: A fiber-reinforced composite prosthesis restoring a lateral midfacial defect: a clinical report. J Prosthet Dent; 2008 Nov;100(5):348-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / rehabilitation. Composite Resins. Eye, Artificial. Female. Glass. Humans. Magnetics / instrumentation. Maxillary Sinus Neoplasms / rehabilitation. Middle Aged. Nose Neoplasms / rehabilitation. Orbital Implants. Silicone Elastomers

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18992568.001).
  • [ISSN] 1097-6841
  • [Journal-full-title] The Journal of prosthetic dentistry
  • [ISO-abbreviation] J Prosthet Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Composite Resins; 0 / Silicone Elastomers; 0 / everStick; 0 / fiberglass
  •  go-up   go-down


76. Fleming JC, Linder JS, Karcioglu ZA: Orbital hyperostosis following exenteration. Ophthal Plast Reconstr Surg; 2008 Sep-Oct;24(5):378-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Sebaceous / surgery. Carcinoma, Basal Cell / surgery. Eyelid Neoplasms / surgery. Hyperostosis / etiology. Orbital Diseases / etiology. Postoperative Complications

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18806659.001).
  • [ISSN] 1537-2677
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


77. Rodríguez-Marco NA, Domínguez-Polo AM, Cristóbal-Bescós JA, Sierra-Barreras J, Castillo-Laguarta J: [Proptosis as the first sign of recurrent scirrhous breast carcinoma]. Arch Soc Esp Oftalmol; 2005 Dec;80(12):737-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • She complained of blurred vision and proptosis of the left eye and these symptoms were the first manifestation of tumor relapse.
  • [MeSH-major] Adenocarcinoma, Scirrhous / secondary. Breast Neoplasms / pathology. Exophthalmos / diagnosis. Neoplasm Recurrence, Local / pathology. Orbital Neoplasms / secondary
  • [MeSH-minor] Antineoplastic Agents / therapeutic use. Diagnosis, Differential. Fatal Outcome. Female. Humans. Middle Aged. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16372219.001).
  • [ISSN] 0365-6691
  • [Journal-full-title] Archivos de la Sociedad Española de Oftalmología
  • [ISO-abbreviation] Arch Soc Esp Oftalmol
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


78. Hajda M, Korányi K, Salomváry B, Bajcsay A: [Clinical presentation, differential diagnosis and treatment of lacrimal gland tumours]. Magy Onkol; 2005;49(1):65-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical presentation, differential diagnosis and treatment of lacrimal gland tumours].
  • Epithelial lacrimal gland tumours, which may be benign or malignant (benign pleomorphic adenoma, malignant pleomorphic adenocarcinoma, adenoid cystic carcinoma, other carcinomas).
  • The differential diagnosis and management are based on the clinical presentations, imaging studies and histological examination.
  • The prognosis of pleomorphic adenomas depends on the early diagnosis and radical surgical excision of the lesion.
  • [MeSH-major] Eye Neoplasms / diagnosis. Eye Neoplasms / therapy. Lacrimal Apparatus. Orbital Diseases / diagnosis. Orbital Diseases / therapy
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / therapy. Adenoma / diagnosis. Adenoma / therapy. Cystadenocarcinoma / diagnosis. Cystadenocarcinoma / therapy. Diagnosis, Differential. Granuloma / diagnosis. Granuloma / therapy. Hodgkin Disease / diagnosis. Hodgkin Disease / therapy. Humans. Leukemia / diagnosis. Leukemia / therapy. Lymphoma / diagnosis. Lymphoma / therapy. Lymphoma, Non-Hodgkin / diagnosis. Lymphoma, Non-Hodgkin / therapy. Orbital Pseudotumor / diagnosis. Orbital Pseudotumor / therapy. Plasmacytoma / diagnosis. Plasmacytoma / therapy. Prognosis. Retrospective Studies. Sarcoidosis / diagnosis. Sarcoidosis / therapy. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15902337.001).
  • [ISSN] 0025-0244
  • [Journal-full-title] Magyar onkologia
  • [ISO-abbreviation] Magy Onkol
  • [Language] hun
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Hungary
  •  go-up   go-down


79. Yu Y, Zhang R, Dai C: [The study on the en bloc resection of the external auditory canal to treat external auditory canal carcinoma in the early stage]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr;23(7):313-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To improve early diagnosis and the effective surgical management of external auditory canal carcinoma.
  • Postoperative pathological diagnosis revealed that 6 cases with adenoid cystic carcinomas, 5 cases of squamous cell carcinomas, 1 case of cerumenal adenocarcinoma.
  • Five cases of squamous cell carcinomas, 1 case of cerumenal adenocarcinoma and 3 cases of adenoid cystic carcinomas received radiotherapy postoperatively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19670611.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


80. Bandyopadhyay S, Adrean SD, Puklin JE, Feng J: Choroidal metastasis from an occult primary diagnosed by fine-needle aspiration: a case report. Diagn Cytopathol; 2009 Jan;37(1):38-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We described fine needle aspiration biopsy (FNAB) of a choroidal mass for diagnosis and determining the primary site.
  • The diagnosis of metastatic adenocarcinoma was rendered.
  • [MeSH-major] Adenocarcinoma / secondary. Choroid Neoplasms / secondary. Eye / pathology. Lung Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Eye Care.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • (PMID = 18973116.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


81. Mao JD, Wu P, Yang YL, Wu J, Huang H: Relationship between expression of gastrin, somatostatin, Fas/FasL and caspases in large intestinal carcinoma. World J Gastroenterol; 2008 May 14;14(18):2802-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / enzymology. Adenocarcinoma / pathology. Adult. Aged. Apoptosis. Caspase 3 / metabolism. Caspase 8 / metabolism. Female. Gene Expression Regulation, Neoplastic. Humans. Male. Middle Aged. RNA, Messenger / metabolism. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell Mol Life Sci. 2004 May;61(9):1042-68 [15112052.001]
  • [Cites] Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):774-7 [17229384.001]
  • [Cites] J Nucl Med. 2004 Oct;45(10):1716-20 [15471839.001]
  • [Cites] Hum Pathol. 1987 Dec;18(12):1268-75 [3315956.001]
  • [Cites] World J Gastroenterol. 2005 Feb 7;11(5):721-5 [15655830.001]
  • [Cites] CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30 [15661684.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • [Cites] Curr Vasc Pharmacol. 2005 Apr;3(2):125-31 [15853632.001]
  • [Cites] Semin Cancer Biol. 2005 Dec;15(6):484-93 [16055342.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2936-42 [16365013.001]
  • [Cites] Horm Metab Res. 2005 Dec;37(12):722-8 [16372224.001]
  • [Cites] Gynecol Endocrinol. 2005 Nov;21(5):248-56 [16373243.001]
  • [Cites] World J Gastroenterol. 2005 Dec 7;11(45):7211-7 [16437675.001]
  • [Cites] Mol Cell Endocrinol. 2006 Mar 9;247(1-2):140-9 [16442704.001]
  • [Cites] Regul Pept. 2006 Mar 15;134(1):1-8 [16169610.001]
  • [Cites] Dev Biol. 2007 Feb 1;302(1):1-12 [16989803.001]
  • [Cites] Dig Dis Sci. 2007 Apr;52(4):1128-33 [17342386.001]
  • [Cites] Endocr Relat Cancer. 2007 Mar;14(1):91-102 [17395978.001]
  • [Cites] Biomed Pharmacother. 2007 Feb-Apr;61(2-3):137-41 [17258885.001]
  • [Cites] Histol Histopathol. 2007 Jul;22(7):743-51 [17455148.001]
  • [Cites] Expert Opin Pharmacother. 2007 May;8(7):895-900 [17472535.001]
  • [Cites] Cancer Lett. 2007 Jul 8;252(1):19-35 [17188424.001]
  • [Cites] World J Gastroenterol. 2007 Aug 7;13(29):4015-8 [17663521.001]
  • [Cites] Neuropeptides. 2007 Oct;41(5):293-9 [17688943.001]
  • [Cites] Zhonghua Yi Xue Za Zhi. 2007 Jun 26;87(24):1704-8 [17825155.001]
  • [Cites] Clin Cancer Res. 2007 Nov 1;13(21):6509-17 [17975164.001]
  • [Cites] Clin Transl Oncol. 2007 Oct;9(10):663-70 [17974527.001]
  • [Cites] Tidsskr Nor Laegeforen. 2007 Nov 1;127(21):2818-23 [17987073.001]
  • [Cites] Gastroenterol Clin North Am. 2007 Dec;36(4):851-65, vi [17996794.001]
  • [Cites] Neuro Endocrinol Lett. 2007 Jun;28(3):250-1 [17627256.001]
  • [Cites] World J Gastroenterol. 2006 Apr 7;12(13):2011-5 [16610049.001]
  • [Cites] J Endocrinol Invest. 2005;28(11 Suppl International):5-9 [16625838.001]
  • [Cites] Endocr Relat Cancer. 2006 Sep;13(3):955-62 [16954443.001]
  • [Cites] Lab Invest. 2006 Oct;86(10):1037-51 [16894354.001]
  • [Cites] Gynakol Geburtshilfliche Rundsch. 2006;46(4):165 [17068400.001]
  • [Cites] Anticancer Res. 2006 Sep-Oct;26(5A):3477-83 [17094470.001]
  • [Cites] Curr Med Chem. 2006;13(27):3307-17 [17168853.001]
  • [Cites] Mol Endocrinol. 2007 Jan;21(1):229-46 [17021051.001]
  • [Cites] Nature. 2001 May 17;411(6835):390-5 [11357148.001]
  • [Cites] Regul Pept. 2001 Sep 15;101(1-3):43-9 [11495678.001]
  • [Cites] Pharmacol Ther. 2001 Oct;92(1):57-70 [11750036.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):155-60 [12490654.001]
  • [Cites] Kaku Igaku. 2003 May;40(2):185-203 [12884785.001]
  • [Cites] Nihon Rinsho. 2003 Sep;61 Suppl 7:25-30 [14574850.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2003 Dec;285(6):G1097-110 [12881229.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1361-6 [14624161.001]
  • [Cites] Cancer. 2004 Mar 15;100(6):1311-23 [15022301.001]
  • [Cites] Rev Prat. 2004 Jan 31;54(2):143-50 [15086056.001]
  • [Cites] Histopathology. 2007 Jan;50(1):30-41 [17204019.001]
  • [Cites] Eur J Histochem. 2006 Oct-Dec;50(4):293-300 [17213038.001]
  • [Cites] Exp Eye Res. 2004 Oct;79(4):465-76 [15381031.001]
  • (PMID = 18473402.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD95; 0 / Fas Ligand Protein; 0 / Gastrins; 0 / RNA, Messenger; 51110-01-1 / Somatostatin; EC 3.4.22.- / Caspase 3; EC 3.4.22.- / Caspase 8; EC 3.4.22.- / Caspases
  • [Other-IDs] NLM/ PMC2710719
  •  go-up   go-down


82. Demirci H, Nelson CC, Shields CL, Eagle RC Jr, Shields JA: Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases. Ophthal Plast Reconstr Surg; 2007 Jan-Feb;23(1):77-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Sebaceous / pathology. Eyelid Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Neoplastic Syndromes, Hereditary / pathology. Sebaceous Gland Neoplasms / pathology

  • Genetic Alliance. consumer health - Keratoacanthoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17237705.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


83. Lee WB, Sy HM, Filip DJ, Grossniklaus HE: Metastatic esophageal adenocarcinoma presenting in the iris. Am J Ophthalmol; 2007 Sep;144(3):477-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic esophageal adenocarcinoma presenting in the iris.
  • PURPOSE: To report a case of metastatic esophageal adenocarcinoma presenting as an acute primary iris tumor of unknown origin.
  • RESULTS: Iris biopsy revealed the lesion represented metastasis, and a systemic evaluation later revealed the primary source as esophageal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / secondary. Esophageal Neoplasms / pathology. Iris Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. EPIRUBICIN .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17765442.001).
  • [ISSN] 0002-9394
  • [Journal-full-title] American journal of ophthalmology
  • [ISO-abbreviation] Am. J. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; 0W860991D6 / Deoxycytidine; 3Z8479ZZ5X / Epirubicin; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


84. Muşat E: [Case solution and plan evaluation in intensity modulation radiotherapy for simple and complex volumes]. Rev Med Chir Soc Med Nat Iasi; 2007 Jan-Mar;111(1):98-105
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: In the first case, the plan with five beams symmetric displayed improved the homogeneity in the PTV (of 0.3%) and the FP (of 24%) and thus, slightly improved CI (0.7 vs. 0.6) when compared with the "beam eye view technique".
  • [MeSH-major] Adenocarcinoma / radiotherapy. Lung Neoplasms / radiotherapy. Mediastinal Neoplasms / radiotherapy. Neoplasm Recurrence, Local. Radiotherapy, Intensity-Modulated
  • [MeSH-minor] Adenocarcinoma, Papillary / radiotherapy. Adenocarcinoma, Papillary / surgery. Algorithms. Ethmoid Sinus. Feasibility Studies. Humans. Male. Middle Aged. Paranasal Sinus Neoplasms / radiotherapy. Paranasal Sinus Neoplasms / surgery. Radiotherapy Dosage. Radiotherapy Planning, Computer-Assisted. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17595852.001).
  • [ISSN] 0048-7848
  • [Journal-full-title] Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i
  • [ISO-abbreviation] Rev Med Chir Soc Med Nat Iasi
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


85. Chang CJ, Lin TK, Wei LC, Wen MC, Tsai HY, Wang JC, Tai MC: Carcinoma ex pleomorphic adenoma of the lacrimal gland: a case report. Ann Ophthalmol (Skokie); 2006;38(2):141-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenoma, Pleomorphic / diagnosis. Eye Neoplasms / diagnosis. Lacrimal Apparatus Diseases / diagnosis

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17416946.001).
  • [ISSN] 1558-9951
  • [Journal-full-title] Annals of ophthalmology (Skokie, Ill.)
  • [ISO-abbreviation] Ann Ophthalmol (Skokie)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


86. Tanaka T, Sato H, Tada A, Moriya T, Wada Y, Nishida K: Case of orbital sebaceous carcinoma developing twenty-seven years after enucleation. Jpn J Ophthalmol; 2008 Jul-Aug;52(4):344-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Sebaceous / pathology. Eye Enucleation. Orbital Neoplasms / pathology. Postoperative Complications

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Exp Ophthalmol. 2004 Feb;32(1):103-5 [14746603.001]
  • [Cites] Arch Ophthalmol. 2001 May;119(5):764-7 [11346408.001]
  • [Cites] Surv Ophthalmol. 2005 Mar-Apr;50(2):103-22 [15749305.001]
  • [Cites] Nippon Ganka Gakkai Zasshi. 2001 Jan;105(1):52-7 [11210789.001]
  • [Cites] Ophthalmology. 1984 May;91(5):497-507 [6739053.001]
  • (PMID = 18773280.001).
  • [ISSN] 0021-5155
  • [Journal-full-title] Japanese journal of ophthalmology
  • [ISO-abbreviation] Jpn. J. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Japan
  •  go-up   go-down


87. Lenaerts K, Bouwman FG, Lamers WH, Renes J, Mariman EC: Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics; 2007;8:91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / chemistry. Adenocarcinoma / genetics. Adenocarcinoma / pathology. Caco-2 Cells. Cell Culture Techniques. Cell Differentiation / genetics. Cell Line, Tumor. Gene Expression Profiling. HT29 Cells. Humans. Intestinal Neoplasms / chemistry. Intestinal Neoplasms / genetics. Intestinal Neoplasms / pathology. Medulloblastoma / chemistry. Medulloblastoma / genetics. Medulloblastoma / pathology. Neoplasm Proteins / analysis. Neoplasm Proteins / biosynthesis. Neoplasm Proteins / genetics. Peptides / analysis. Peptides / genetics

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Lipid Res. 1987 Jun;28(6):739-45 [3611975.001]
  • [Cites] Biochimie. 1986 Sep;68(9):1035-40 [3096381.001]
  • [Cites] Carcinogenesis. 1989 May;10(5):899-905 [2650908.001]
  • [Cites] Drug Metab Dispos. 1989 May-Jun;17(3):255-64 [2568905.001]
  • [Cites] J Cell Biol. 1990 Aug;111(2):567-80 [1696264.001]
  • [Cites] Exp Eye Res. 1992 Jul;55(1):163-71 [1339354.001]
  • [Cites] J Biol Chem. 1993 Apr 15;268(11):8267-76 [8463337.001]
  • [Cites] J Biol Chem. 1994 Feb 18;269(7):5297-302 [8106514.001]
  • [Cites] Arch Biochem Biophys. 1995 Mar 10;317(2):385-90 [7893153.001]
  • [Cites] In Vitro Cell Dev Biol Anim. 1997 Feb;33(2):118-28 [9081219.001]
  • [Cites] J Cell Physiol. 1998 Mar;174(3):362-9 [9462698.001]
  • [Cites] Histol Histopathol. 1999 Oct;14(4):1277-86 [10506943.001]
  • [Cites] Proteomics. 2004 Dec;4(12):3855-63 [15540163.001]
  • [Cites] Rapid Commun Mass Spectrom. 2005;19(17):2465-8 [16059887.001]
  • [Cites] Eur J Cancer Prev. 2005 Oct;14(5):439-57 [16175049.001]
  • [Cites] Infect Immun. 2005 Dec;73(12):8204-8 [16299316.001]
  • [Cites] Curr Mol Med. 2006 Feb;6(1):45-54 [16472112.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G827-38 [16537974.001]
  • [Cites] Proteomics. 2006 Apr;6(8):2600-8 [16502466.001]
  • [Cites] Proteomics. 2006 Apr;6(8):2454-64 [16548066.001]
  • [Cites] Biochim Biophys Acta. 2006 Apr;1765(2):85-100 [16378690.001]
  • [Cites] J Proteome Res. 2006 Sep;5(9):2113-22 [16944922.001]
  • [Cites] J Gastrointest Surg. 1997 Sep-Oct;1(5):433-8; discussion 438 [9834375.001]
  • [Cites] Proteomics. 2007 Feb;7(4):565-77 [17309102.001]
  • [Cites] Nat Genet. 2000 Mar;24(3):227-35 [10700174.001]
  • [Cites] Biol Pharm Bull. 2000 Jul;23(7):810-4 [10919357.001]
  • [Cites] J Cell Biochem. 2001;81(4):613-20 [11329616.001]
  • [Cites] J Biol Chem. 2001 Dec 14;276(50):47542-9 [11598139.001]
  • [Cites] Gut. 2002 Feb;50(2):201-5 [11788560.001]
  • [Cites] J Cell Sci. 2002 Sep 15;115(Pt 18):3587-99 [12186945.001]
  • [Cites] Gut. 2003 Feb;52(2):224-30 [12524404.001]
  • [Cites] Mol Biol Cell. 2003 Jul;14(7):2959-71 [12857878.001]
  • [Cites] Biochim Biophys Acta. 2003 Aug 21;1650(1-2):73-91 [12922171.001]
  • [Cites] Clin Biochem. 2003 Oct;36(7):529-35 [14563446.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Mar;36(3):379-85 [14687915.001]
  • [Cites] World J Gastroenterol. 2004 Feb 15;10(4):509-13 [14966907.001]
  • [Cites] Biochemistry. 1969 Jan;8(1):109-21 [5777313.001]
  • [Cites] Anal Biochem. 1976 May 7;72:248-54 [942051.001]
  • [Cites] Science. 1980 Oct 10;210(4466):195-8 [6774420.001]
  • [Cites] J Cell Physiol. 1985 Jan;122(1):21-9 [3880764.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Jul;82(14):4707-11 [3860818.001]
  • [Cites] Gastroenterology. 1989 Mar;96(3):736-49 [2914637.001]
  • (PMID = 17407598.001).
  • [ISSN] 1471-2164
  • [Journal-full-title] BMC genomics
  • [ISO-abbreviation] BMC Genomics
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / Peptides; 0 / Proteins
  • [Other-IDs] NLM/ PMC1852558
  •  go-up   go-down


88. Inoue M, Watanabe Y, Yamane S, Kobayashi S, Arakawa A, Tsukahara T, Kaneko T, Kadonosono K: Choroidal metastasis with adenocarcinoma of the lung treated with gefitinib. Eur J Ophthalmol; 2010 Sep-Oct;20(5):963-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Choroidal metastasis with adenocarcinoma of the lung treated with gefitinib.
  • PURPOSE: To report a case of bilateral regression of choroidal metastasis with adenocarcinoma of the lung treated with gefitinib.
  • METHODS: Retrospective case review of a 68-year-old woman with pulmonary adenocarcinoma with choroidal metastasis who presented with visual loss in the left eye as the initial manifestation.
  • Her visual acuity was 6/6 in the right eye and 6/60 in the left eye before the start of gefitinib administration.
  • RESULTS: Best-corrected visual acuity in the left eye had improved to 6/30 3 months after oral gefitinib.
  • The elevated lesions of the right eye disappeared, with decrease of subretinal fluid and retinal pigment epithelial atrophy.
  • Spectral-domain optical coherence tomography showed that subretinal fluid of the left eye was also reduced.
  • CONCLUSIONS: Oral gefitinib could be effective for regression of choroidal metastasis in patients with adenocarcinoma of the lung and provides a potential treatment option.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Agents / therapeutic use. Choroid Neoplasms / drug therapy. Lung Neoplasms / drug therapy. Quinazolines / therapeutic use

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20383850.001).
  • [ISSN] 1724-6016
  • [Journal-full-title] European journal of ophthalmology
  • [ISO-abbreviation] Eur J Ophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Quinazolines; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; S65743JHBS / gefitinib
  •  go-up   go-down


89. Kannan V, Sathiyanarayanan VK, Sagde S, Anand V, Almel S, Kapadia A, Srinivas V: Three dimensional conformal radiation therapy in prostate adenocarcinoma: survival and rectal toxicity. J Cancer Res Ther; 2005 Jan-Mar;1(1):34-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Three dimensional conformal radiation therapy in prostate adenocarcinoma: survival and rectal toxicity.
  • Treatment method consisted of pelvis and leg immobilization, planning CT scan, marking of planning target volume and organs at risk and 3D beam plan using multileaf collimated beam shaping through beam's eye view display.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Prostatic Neoplasms / radiotherapy. Rectum / radiation effects

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17998623.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


90. Ye XH, Zhou SJ, Chen X, Wang KY, Wang QM, Qu J: [Modified transcranial orbitotomy for treating exophthalmic intraorbital tumor]. Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Nov;21(6):405-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumor included adenocarcinoma of the lacrimal gland, neurinoma, meningioma, and cavernous hemangioma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16463772.001).
  • [ISSN] 1009-4598
  • [Journal-full-title] Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery
  • [ISO-abbreviation] Zhonghua Zheng Xing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


91. Ranck RS, Cullen JM, Waggie KS, Marion PL: Harderian gland neoplasms in captive, wild-caught Beechey ground squirrels (Spermophilus beecheyi). Vet Pathol; 2008 May;45(3):388-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Eye Neoplasms / veterinary. Harderian Gland / pathology. Neoplasms / veterinary. Sciuridae
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / veterinary. Animals. Animals, Wild. Female. Functional Laterality. Male

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18487500.001).
  • [ISSN] 0300-9858
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


92. Brovkina AF, Tadzhieva ZA, Sherstnev VV: [Clinical and epidemiological study of lacrimal neoplasms]. Vestn Oftalmol; 2009 May-Jun;125(3):3-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The survival rates closely correlated with the higher rates of recurrent adenocarcinoma and adenocystic cancer (r = -0.87).
  • [MeSH-major] Eye Neoplasms / epidemiology. Lacrimal Apparatus
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Morbidity. Population Surveillance. Retrospective Studies. Tajikistan / epidemiology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19566038.001).
  • [ISSN] 0042-465X
  • [Journal-full-title] Vestnik oftalmologii
  • [ISO-abbreviation] Vestn Oftalmol
  • [Language] rus
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


93. Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B: Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg; 2007 Aug;133(8):820-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Sebaceous / pathology. Eye Neoplasms / pathology. Melanoma / pathology. Sebaceous Gland Neoplasms / pathology. Sentinel Lymph Node Biopsy

  • Genetic Alliance. consumer health - Ocular melanoma.
  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17709624.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Alsuhaibani AH, Carter KD, Nerad JA, Lee AG: Prostate carcinoma metastasis to extraocular muscles. Ophthal Plast Reconstr Surg; 2008 May-Jun;24(3):233-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Orbital involvement is uncommon and extraocular muscle enlargement is a rare presentation of metastatic prostate adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / secondary. Eye Neoplasms / secondary. Muscle Neoplasms / secondary. Oculomotor Muscles / pathology. Prostatic Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18520846.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


95. Akda F, Hafezi F, Heule-Dieleman HA, van den Bosch WA, Luyten GP, Tanghe HL, Paridaens D: [Orbital metastases of breast cancer. Radiologic features]. Ophthalmologe; 2010 Aug;107(8):728-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / diagnosis. Magnetic Resonance Imaging. Orbital Neoplasms / diagnosis. Orbital Neoplasms / secondary. Tomography, X-Ray Computed
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Adenocarcinoma / secondary. Adenocarcinoma, Scirrhous / diagnosis. Adenocarcinoma, Scirrhous / diagnostic imaging. Adenocarcinoma, Scirrhous / pathology. Adult. Aged. Aged, 80 and over. Biopsy. Diagnosis, Differential. Eye Diseases / diagnosis. Eye Diseases / pathology. Female. Humans. Lymphatic Metastasis. Middle Aged. Neoplasm Staging. Orbit / pathology. Retrospective Studies. Vision Disorders / diagnosis. Vision Disorders / pathology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1976 Sep;38(3):1326-35 [953971.001]
  • [Cites] Surv Ophthalmol. 1990 Jul-Aug;35(1):1-24 [2204127.001]
  • [Cites] Am J Ophthalmol. 1967 Apr;63(4):723-6 [6022244.001]
  • [Cites] Ophthalmology. 1998 Oct;105(10):1897-901 [9787361.001]
  • [Cites] Arch Ophthalmol. 1971 Jun;85(6):673-5 [5562786.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2001 Sep;17 (5):346-54 [11642491.001]
  • [Cites] Arch Ophthalmol. 1987 Sep;105(9):1215-9 [3307718.001]
  • [Cites] Br J Ophthalmol. 1997 May;81(5):386-90 [9227204.001]
  • [Cites] Arch Ophthalmol. 1974 Oct;92(4):276-86 [4412321.001]
  • [Cites] Ophthalmology. 1990 May;97(5):620-4 [2342807.001]
  • [Cites] Jpn J Ophthalmol. 1995;39(1):65-70 [7643486.001]
  • [Cites] Orbit. 2003 Mar;22(1):15-24 [12759863.001]
  • (PMID = 20393728.001).
  • [ISSN] 1433-0423
  • [Journal-full-title] Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
  • [ISO-abbreviation] Ophthalmologe
  • [Language] ger
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


96. Melo DH, Pierre Filho Pde T, Gomes PR, Holanda AG, Amadei LP: [Choroidal metastasis of gastric adenocarcinoma as a first sign of systemic disease recurrence: case report]. Arq Bras Oftalmol; 2010 Sep-Oct;73(5):467-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Choroidal metastasis of gastric adenocarcinoma as a first sign of systemic disease recurrence: case report].
  • [Transliterated title] Metástase de adenocarcinoma gástrico para a coróide como um primeiro sinal de recorrência de doença sistêmica: relato de caso.
  • To describe a patient with unilateral metastatic choroidal gastric adenocarcinoma as a first sign of systemic dissemination.
  • A 54-year-old woman presented with a 7-month history of progressive pain and decrease in vision in her left eye.
  • She had undergone total gastrectomy due to gastric adenocarcinoma two years previously.
  • Examination of the left eye revealed an elevated creamy yellow choroidal tumor infiltrating the macular area and extending around the optic nerve head, suggesting metastasis.
  • Treatment was enucleation of the affected eye.
  • This patient represents a rare occurrence of metastatic gastric adenocarcinoma to the choroid, developing as a first sign of systemic recurrence.
  • [MeSH-major] Adenocarcinoma / secondary. Choroid Neoplasms / secondary. Orbital Neoplasms / secondary. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21225136.001).
  • [ISSN] 1678-2925
  • [Journal-full-title] Arquivos brasileiros de oftalmologia
  • [ISO-abbreviation] Arq Bras Oftalmol
  • [Language] por
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


97. Hase R, Miyamoto M, Uehara H, Kadoya M, Ebihara Y, Murakami Y, Takahashi R, Mega S, Li L, Shichinohe T, Kawarada Y, Kondo S: Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Clin Cancer Res; 2005 Dec 15;11(24 Pt 1):8737-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Pigment epithelium-derived factor (PEDF), which has recently been shown to be the most potent inhibitor of angiogenesis in the mammalian eye, is also expressed in the pancreas.
  • EXPERIMENTAL DESIGN: We investigated both in vitro and in vivo growth characteristics of human pancreatic adenocarcinoma cell lines that were stably transfected to overexpress human PEDF and therapeutic effects of lentivirus-based vectors expressing PEDF on tumor growth in murine s.c. tumor model.
  • The size of PEDF-overexpressing pancreatic adenocarcinoma tumors was significantly smaller than that of control tumors in s.c. tumor models.
  • Moreover, the growth of PEDF-overexpressing pancreatic adenocarcinoma cells was significantly suppressed in comparison with control cells in peritoneal metastasis models.
  • CONCLUSION: Our data suggest that PEDF may exert a biological effect on tumor angiogenesis and PEDF gene therapy may provide a new approach for treatment of pancreatic adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / therapy. Eye Proteins / genetics. Genetic Therapy. Neovascularization, Pathologic / therapy. Nerve Growth Factors / genetics. Pancreatic Neoplasms / therapy. Serpins / genetics

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16361561.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Eye Proteins; 0 / Nerve Growth Factors; 0 / RNA, Messenger; 0 / Serpins; 0 / pigment epithelium-derived factor
  •  go-up   go-down


98. Piazuelo E, Cebrián C, Escartín A, Jiménez P, Soteras F, Ortego J, Lanas A: Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. World J Gastroenterol; 2005 Dec 21;11(47):7436-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus.
  • AIM: To test whether antioxidant treatment could prevent the progression of Barrett's esophagus to adenocarcinoma.
  • The process was associated with a progressive presence of intestinal metaplasia beyond the anastomotic area (9% 1st mo and 50% 4th mo) (94% at the anastomotic level) and adenocarcinoma (11% 1st mo and 60% 4th mo).
  • Exogenous administration of SOD decreased mucosal superoxide levels, increased mucosal SOD levels and reduced the risk of developing intestinal metaplasia beyond the anastomotic area (odds ratio = 0.326; 95%CI: 0.108-0.981; P = 0.046), and esophageal adenocarcinoma (odds ratio = 0.243; 95%CI: 0.073-0.804; P = 0.021).
  • CONCLUSION: Superoxide dismutase prevents the progression of esophagitis to Barrett's esophagus and adenocarcinoma in this rat model of gastrointestinal reflux, supporting a role of antioxidants in the chemoprevention of esophageal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / prevention & control. Barrett Esophagus / drug therapy. Esophageal Neoplasms / prevention & control. Free Radical Scavengers / pharmacology. Superoxide Dismutase / pharmacology

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16437713.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Free Radical Scavengers; EC 1.15.1.1 / Superoxide Dismutase
  • [Other-IDs] NLM/ PMC4725177
  •  go-up   go-down


99. Chen J, Ye L, Zhang L, Jiang WG: The molecular impact of pigment epithelium-derived factor, PEDF, on lung cancer cells and the clinical significance. Int J Oncol; 2009 Jul;35(1):159-66
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / metabolism. Carcinoma, Squamous Cell / metabolism. Eye Proteins / metabolism. Lung Neoplasms / metabolism. Nerve Growth Factors / metabolism. Serpins / metabolism. Small Cell Lung Carcinoma / metabolism. Tumor Suppressor Proteins / metabolism

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19513563.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Grant] United Kingdom / Cancer Research UK / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Eye Proteins; 0 / Nerve Growth Factors; 0 / Recombinant Proteins; 0 / Serpins; 0 / Tumor Suppressor Proteins; 0 / pigment epithelium-derived factor
  •  go-up   go-down


100. Ivanova MM, Mazhawidza W, Dougherty SM, Minna JD, Klinge CM: Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells. Mol Cell Endocrinol; 2009 Jun 16;305(1-2):12-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We reported estrogenic transcriptional responses in lung adenocarcinoma cells from females but not males despite similar estrogen receptor (ER) expression.
  • In contrast to lung adenocarcinoma cells, estradiol (E2) induced estrogen response element (ERE)-mediated luciferase reporter activity in transiently transfected HBECs regardless of donor gender.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • GeneTex Inc. NCBI Redirect Page | Genetex Inc. (subscription/membership/fee required).
  • Hazardous Substances Data Bank. ESTRADIOL .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Breast Cancer Res Treat. 1994;31(1):95-105 [7981461.001]
  • [Cites] J Biol Chem. 1995 Jul 28;270(30):18019-25 [7629110.001]
  • [Cites] Nature. 1995 Oct 5;377(6548):454-7 [7566127.001]
  • [Cites] Mol Endocrinol. 1995 Jun;9(6):659-69 [8592512.001]
  • [Cites] Oncogene. 1996 Jun 6;12(11):2315-24 [8649771.001]
  • [Cites] Endocrinology. 1997 Mar;138(3):863-70 [9048584.001]
  • [Cites] Cell. 1997 May 2;89(3):373-80 [9150137.001]
  • [Cites] Endocrinology. 1997 Nov;138(11):4613-21 [9348186.001]
  • [Cites] Pharmacol Rev. 1998 Jun;50(2):151-96 [9647865.001]
  • [Cites] Oncol Rep. 1998 Sep-Oct;5(5):1025-33 [9683804.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2639-44 [10077563.001]
  • [Cites] J Mol Endocrinol. 2004 Oct;33(2):387-410 [15525597.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2004 Dec;287(6):L1154-9 [15298854.001]
  • [Cites] Cancer Res. 2004 Dec 15;64(24):9027-34 [15604268.001]
  • [Cites] Cancer Res. 2005 Feb 15;65(4):1459-70 [15735034.001]
  • [Cites] Cancer Res. 2005 Feb 15;65(4):1598-605 [15735050.001]
  • [Cites] Steroids. 2005 May-Jun;70(5-7):372-81 [15862820.001]
  • [Cites] Cancer Res. 2005 Jul 15;65(14):6450-8 [16024650.001]
  • [Cites] Mol Carcinog. 2005 Nov;44(3):202-11 [16010691.001]
  • [Cites] Clin Cancer Res. 2005 Oct 15;11(20):7280-7 [16243798.001]
  • [Cites] Endocrinology. 2005 Dec;146(12):5474-84 [16150902.001]
  • [Cites] Hum Reprod. 2005 Dec;20(12):3481-7 [16123086.001]
  • [Cites] Cancer Res. 2005 Dec 15;65(24):11287-91 [16357134.001]
  • [Cites] J Cell Biochem. 2006 Mar 1;97(4):673-83 [16329141.001]
  • [Cites] Endocr Relat Cancer. 2006 Mar;13(1):113-34 [16601283.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2006 May;290(5):L866-70 [16361355.001]
  • [Cites] Mol Biol Cell. 2006 May;17(5):2125-37 [16495339.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 May 2;103(18):7165-9 [16636272.001]
  • [Cites] Am J Respir Crit Care Med. 2006 Sep 1;174(5):524-9 [16778158.001]
  • [Cites] Genes Dev. 2006 Sep 15;20(18):2513-26 [16980581.001]
  • [Cites] Lung Cancer. 2007 Jan;55(1):1-14 [17070615.001]
  • [Cites] Toxicol Sci. 2007 Feb;95(2):313-20 [17077188.001]
  • [Cites] CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 [17237035.001]
  • [Cites] Steroids. 2007 Feb;72(2):135-43 [17276470.001]
  • [Cites] Arch Oral Biol. 2007 Jul;52(7):669-76 [17223066.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L222-8 [17449797.001]
  • [Cites] Carcinogenesis. 2007 Jul;28(7):1606-12 [17272310.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L272-8 [17575008.001]
  • [Cites] Mol Cell Biol. 2007 Sep;27(17):5933-48 [17591692.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L568-9 [17631611.001]
  • [Cites] Trends Endocrinol Metab. 2007 Oct;18(8):308-13 [17764971.001]
  • [Cites] Allergy. 2008 Jan;63(1):47-57 [17822448.001]
  • [Cites] Am J Respir Crit Care Med. 2007 Dec 15;176(12):1179-84 [17673696.001]
  • [Cites] Biochim Biophys Acta. 2007 Dec;1773(12):1732-46 [17604135.001]
  • [Cites] Pathol Int. 2008 Jan;58(1):17-25 [18067636.001]
  • [Cites] J Clin Oncol. 2007 Dec 20;25(36):5785-92 [18089876.001]
  • [Cites] Mol Endocrinol. 2008 Mar;22(3):609-22 [18048642.001]
  • [Cites] Am J Respir Crit Care Med. 2008 Apr 15;177(8):928; author reply 928-9 [18390965.001]
  • [Cites] Am J Respir Cell Mol Biol. 2008 May;38(5):501-8 [18063836.001]
  • [Cites] Am J Respir Cell Mol Biol. 2008 May;38(5):499-500 [18417757.001]
  • [Cites] Endocr Relat Cancer. 2008 Jun;15(2):475-83 [18509000.001]
  • [Cites] Clin Cancer Res. 2008 Jul 15;14(14):4417-26 [18579664.001]
  • [Cites] Mol Endocrinol. 2008 Oct;22(10):2213-4 [18701638.001]
  • [Cites] J Biol Chem. 1999 Nov 19;274(47):33551-6 [10559241.001]
  • [Cites] Endocrinology. 1999 Dec;140(12):5566-78 [10579320.001]
  • [Cites] Steroids. 2000 May;65(5):227-51 [10751636.001]
  • [Cites] Mol Cell Endocrinol. 2000 Jul 25;165(1-2):151-61 [10940493.001]
  • [Cites] EMBO J. 2000 Sep 1;19(17):4688-700 [10970861.001]
  • [Cites] Am J Respir Crit Care Med. 2000 Dec;162(6):2152-8 [11112130.001]
  • [Cites] J Cell Biochem. 2001;82(3):467-79 [11500923.001]
  • [Cites] Cancer Res. 2002 Apr 1;62(7):2141-50 [11929836.001]
  • [Cites] Exp Hematol. 2002 Jun;30(6):503-12 [12063017.001]
  • [Cites] EMBO J. 2002 Jul 1;21(13):3443-53 [12093745.001]
  • [Cites] Lung Cancer. 2002 Aug;37(2):153-9 [12140138.001]
  • [Cites] J Mol Endocrinol. 2002 Aug;29(1):23-39 [12200227.001]
  • [Cites] J Mol Endocrinol. 2002 Aug;29(1):137-52 [12200235.001]
  • [Cites] Mol Cell. 2002 Nov;10(5):1019-32 [12453411.001]
  • [Cites] Mol Cell Biol. 2003 Dec;23(23):8542-52 [14612399.001]
  • [Cites] Arch Intern Med. 2004 Feb 23;164(4):379-86 [14980988.001]
  • [Cites] Exp Eye Res. 2004 Apr;78(4):861-71 [15037120.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4130-5 [15024130.001]
  • [Cites] Br J Cancer. 2004 May 17;90(10):1942-8 [15138475.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E1011-22 [14736707.001]
  • [Cites] J Biol Chem. 2004 Jun 18;279(25):26184-91 [15078875.001]
  • [Cites] Steroids. 2004 May;69(5):351-6 [15219413.001]
  • [Cites] Mol Endocrinol. 1994 Jan;8(1):21-30 [8152428.001]
  • (PMID = 19433257.001).
  • [ISSN] 1872-8057
  • [Journal-full-title] Molecular and cellular endocrinology
  • [ISO-abbreviation] Mol. Cell. Endocrinol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P50 CA070907-12; United States / NCI NIH HHS / CA / CA070907-12; United States / NCI NIH HHS / CA / P50CA70907; None / None / / P50 CA070907-11; None / None / / P50 CA070907-10; United States / NCI NIH HHS / CA / P50 CA070907-11; United States / NCI NIH HHS / CA / P50 CA070907; United States / NCI NIH HHS / CA / P50 CA070907-10
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Estrogen Receptor alpha; 0 / Estrogen Receptor beta; 0 / Hydroxytestosterones; 2141-17-5 / 4,17 beta-dihydroxy-4-androstene-3-one; 4TI98Z838E / Estradiol
  • [Other-IDs] NLM/ NIHMS148501; NLM/ PMC2767333
  •  go-up   go-down






Advertisement